Aromatic heterocyclic compound, and pharmaceutical composition and use thereof
US11679108B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | May 22, 2019 |
| Grant date | Jun 20, 2023 |
| Priority date | — |
| Expiry date | May 22, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are novel heteroaromatic compound as an Autotaxin inhibitor, a pharmaceutical composition comprising the compound, and a use thereof in a treatment of a disease with a pathological feature of Autotaxin overexpression in a mammal, wherein the compound is according to formula (I), or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, tautomer, nitrogen oxide, metabolite, prodrug, or mixture thereof; wherein each of R1, Ar1, Ar2, Ar3, W, Y, Z, and Cy is defined in the present disclosure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.